GENinCode (LSE:GENI) OCF Margin %: -61.67% (As of Dec. 2025)


What is GENinCode OCF Margin %?

GENinCode LSE:GENI +5.56% OCF Margin % is -61.67% as of Dec. 2025. The stock has 4 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, GENinCode ranks worse than 83.33% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. GENinCode's Cash Flow from Operations for the six months ended in Dec. 2025 was £-0.91 Mil. GENinCode's Revenue for the six months ended in Dec. 2025 was £1.47 Mil. Therefore, GENinCode's OCF Margin % for the quarter that ended in Dec. 2025 was -61.67%.

As of today, GENinCode's current OCF Yield % is -57.65%.

The historical rank and industry rank for GENinCode's OCF Margin % or its related term are showing as below:

LSE:GENI' s OCF Margin % Range Over the Past 10 Years
Min: -347.5   Med: -226.01   Max: -108.01
Current: -134.07

During the past 7 years, the highest OCF Margin % of GENinCode was -108.01%. The lowest was -347.50%. And the median was -226.01%.

LSE:GENI's OCF Margin % is ranked worse than
83.33% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: 4.755 vs LSE:GENI: -134.07

GENinCode OCF Margin % Related Terms

GENinCode OCF Margin % Historical Data

* Premium members only.

The historical data trend for GENinCode's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GENinCode OCF Margin % Chart

GENinCode Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial -268.11 -260.49 -347.50 -191.52 -134.07

GENinCode Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -221.74 -243.99 -135.98 -200.69 -61.67

LSE:GENI vs TMO, DHR, IDXX: OCF Margin % Comparison

For the Diagnostics & Research subindustry, GENinCode's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GENinCode OCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, GENinCode's OCF Margin % distribution charts can be found below:

* The bar in red indicates where GENinCode's OCF Margin % falls into.


GENinCode OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

GENinCode's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-4.124/3.076
=-134.07 %

GENinCode's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-0.909/1.474
=-61.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -61.67% mean?
GENinCode (LSE:GENI) has a OCF Margin % of -61.67% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on GENinCode and its competitors. According to the industry distribution chart, GENinCode ranks #170 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 83.3%.
Is GENinCode's OCF Margin % too high?
GENinCode's current OCF Margin % is -61.67%. Based on the distribution chart, GENinCode ranks #170 out of 204 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does GENinCode's OCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, GENinCode ranks #170 out of 204 companies for OCF Margin %. This places GENinCode in the lower half of its industry. The industry median OCF Margin % is 4.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Diagnostics & Research company?
The median OCF Margin % among Medical Diagnostics & Research companies is 4.76, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on GENinCode and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 4.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GENinCode's current OCF Margin % is -61.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GENinCode stock overvalued right now?
Based on GuruFocus' analysis, GENinCode (LSE:GENI) is currently considered Possible Value Trap. The stock's GF Value™ is £0.04, compared to a current price of £0.01 — trading 76.3% below its estimated fair value. The current OCF Margin % is -61.67%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For GENinCode (LSE:GENI), the current OCF Margin % is -61.67% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GENinCode Business Description

Address Oxford Science Park, John Eccles House, Robert Robertson Avenue, Oxford, GBR, OX4 4GP
GENinCode PLC principal activity is the development and commercialisation of clinical genetic tests, to provide predictive analysis of risk to a patient's health based on their genes. The company has one operating segment. The company has presence in Spain, UK, United States, Italy, Germany, and Rest of World. The company generates majority of revenue from Spain. Its commercial products are CE-Marked, with CARDIO inCode, THROMBO inCode, and LIPID inCode.